Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements. [PDF]
J Manag Care Spec Pharm, 2022 Alexander WA +6 more
europepmc +1 more source
Economic Boom and Social Mobility: The Irish Experience [PDF]
In this paper we examine the consequences for social mobility patterns of the unprecedented period of economic growth experienced in Ireland over the 1990s and the implications of developments for current theories of social fluidity.
Christopher T. Whelan, Richard Layte
core
Recombinant Factor VIIa Prophylaxis in 2 Brothers with Bernard-Soulier Syndrome. [PDF]
Am J Case RepAlmatar E, Alsharidah S, Hashem OA.
europepmc +1 more source
MicroRNA-22 Regulates Smooth Muscle Cell Differentiation From Stem Cells by Targeting Methyl CpG-Binding Protein 2 [PDF]
, 2015 Guanmei Wen +11 more
core +1 more source
The effect of recombinant factor VIIa treatment in non-traumatic intracranial hemorrhage: Systematic review and meta-analysis [PDF]
Dalal Aldhafeeri +12 more
openalex +1 more source
Regulation of factor VIIa/tissue factor functional activity in an umbilical vein model. [PDF]
, 1993 Fanny E Almus +2 more
openalex +1 more source
Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism. [PDF]
BloodSedzro JC +11 more
europepmc +1 more source
Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety. [PDF]
Res Pract Thromb Haemost, 2021 Mahlangu J +8 more
europepmc +1 more source
Rational Use of Recombinant Factor VIIa in Clinical Practice
Indian Journal of Hematology and Blood Transfusion, 2014 T. Dutta, S. Verma
semanticscholar +1 more source